1. P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry. (25th January 2019) Authors: Calafat, M; Mañosa, M; Panes, J; Nos, P; Iglesias, E; Vera, I; López-Sanromán, A; Guardiola, J; Taxonera, C; Mínguez, M; Martín, M D; de Castro, L; Riestra, S; Rivero, M; García-Planella, E; Calvet, X; García-López, S; Andreu, M; Gomollón, F; Barrio, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗